Dyadic International, Inc. ( Dyadic , we , us , our , or the Company ), doing business as Dyadic Applied BioSolutions, is a global biotechnology company based in Jupiter, Florida, with operations in the United States and a satellite office in the Netherlands. The Company develops, manufactures, and commercializes precision-engineered, animal-free recombinant proteins and enzymes for ap…
The business is unprofitable at the operating level (-232.75% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 11.6% YoY. Margins deteriorated 63.9pp alongside, both lines moving the wrong way.
ROIC dropped from -108.73% to -297.02%, capital efficiency is deteriorating. Operating margin contracted 63.9pp YoY, cost discipline may be slipping.
Profitability & Returns
Revenue (TTM)
$4M
▼ -11.6% YoY
Net Income (TTM)
-$7M
▼ -26.8% YoY
Op. Margin
-186.28%
▼ -63.9pp YoY
ROIC
-559.52%
▼ -188.3pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$6M
▼ -43.5% YoY
Net Debt
-$6M
Net Cash Position
Cash & Equiv.
$6M
5Y CAGR: +14.0%
Continue Research